本港新增5宗輸入新冠確診
衛生署公佈,截至10月18日零時零分,中心正調查5宗新增新冠確診個案,至今本港累計12,299宗確診。
新增個案均爲輸入個案,全部涉及變異病毒株的感染。個案涉及5名男子,年齡介乎29至59歲,當中3人由A組指明地區(高風險)抵港,兩人由B組指明地區(中風險)抵港。其中4人抵港時在香港國際機場臨時樣本採集中心「檢測待行」的檢測結果呈陽性,餘下一人在檢疫期間檢測確診。
過去14天累計報告68宗個案,包括一宗源頭不明本地個案,其餘均爲輸入個案。
另外,由於卡塔爾航空營運的分別於本月13日和16日由卡塔爾多哈飛抵香港的兩個航班(QR818),各有兩名乘客經抵港檢測而確診,衛生署遂引用規例,禁止卡塔爾航空營運的客機在10月18日至31日期間從多哈着陸香港。
中心亦提醒與沙田翠田街5-7號金獅花園第一期金輝閣相關的指明人士,須於明日(19日)遵從強制檢測公告進行檢測。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.